Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 210, Issue 6, Pages 1125-1135
Publisher
Rockefeller University Press
Online
2013-05-28
DOI
10.1084/jem.20130110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- The establishment of a bank of stored clinical bone marrow stromal cell products
- (2012) Marianna Sabatino et al. Journal of Translational Medicine
- Endothelial and perivascular cells maintain haematopoietic stem cells
- (2012) Lei Ding et al. NATURE
- Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
- (2012) S. A. Rosenberg Science Translational Medicine
- Understanding the role of stromal fibroblasts in cancer progression
- (2012) Manisha Tripathi et al. Cell Adhesion & Migration
- The bone marrow stroma in hematological neoplasms—a guilty bystander
- (2011) Claudio Tripodo et al. Nature Reviews Clinical Oncology
- The elusive nature and function of mesenchymal stem cells
- (2011) César Nombela-Arrieta et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model
- (2010) Yuan Wen et al. CANCER SCIENCE
- Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
- (2010) Simón Méndez-Ferrer et al. NATURE
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
- (2009) Robert M Eager et al. BMC CANCER
- Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
- (2009) R.M. Eager et al. CLINICAL ONCOLOGY
- The promise and potential pitfalls of chimeric antigen receptors
- (2009) Michel Sadelain et al. CURRENT OPINION IN IMMUNOLOGY
- Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”
- (2009) Gianpietro Dotti et al. HUMAN GENE THERAPY
- Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
- (2009) Angélica M. Santos et al. JOURNAL OF CLINICAL INVESTIGATION
- Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow
- (2009) Satoru Morikawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
- (2009) Debbie Liao et al. PLoS One
- Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow
- (2008) Sohyun Bae et al. BRITISH JOURNAL OF HAEMATOLOGY
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
- (2008) E. Ostermann et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now